BioSpace News Archive

Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today announced that the U.S. Department of Commerce has selected Brendan O’Grady, Executive Vice President and Head of North America Commercial to serve on the U.S. Investment Advisory Council.

ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, today announced that Dr. Steve Cutler, CEO and Mr. Brendan Brennan, CFO of ICON plc, will present at Baird’s 2019 Global Healthcare Conference on Thursday, September 5, 2019.

Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that owing to a change in format, management will deliver a corporate presentation at the 2019 Wells Fargo Healthcare Conference at 3:35 p.m. Eastern time on September 4th.

On September 1, Texas Gov. Greg Abbott signed into law a bill that eliminates the requirement for patients to obtain a doctor’s prescription prior to seeking treatment from a licensed physical therapist.

Mallinckrodt plc reported the company has finalized a previously disclosed agreement with the U.S. Department of Justice to resolve a civil False Claims Act investigation of Questcor’s legacy sales and marketing activities first filed in 2012.

New Clinical Study will document caries reduction in moderate and high caries risk patients

Capital BlueCross has thousands of members who live and work on the Carolina Coast

Exelixis, Inc. (Nasdaq: EXEL) today announced that Michael M. Morrissey, Ph.D., the company’s President and Chief Executive Officer, will provide a corporate overview at the Morgan Stanley 17th Annual Global Healthcare Conference

Nextleaf Solutions Ltd. (“Nextleaf”, “OILS”, or the “Company”) (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) announced today it has been granted a U.S. patent pertaining to the Company’s proprietary technology for post-extraction processing of THC and CBD.

Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at 9:35 a.m. EDT on Tuesday, September 10,